IOVAIovance Biotherapeutics, Inc.Signing up patients
Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer
Metastatic Non Small Cell Lung Cancer
0Calmworry score, out of 100
No strong warning signs right now. The score counts warning signs; it is not a prediction.
Why this score
No warning signs right now. That's why the score is 0.
Score over time
- Stage
- Phase 2
- Patients
- 170 (planned)
- Started
- May 7, 2021
- Main results expected
- Dec 2030
- Fully finished
- Dec 2031
- Results posted
- not yet
What counts as success
The trial's main goal(s), called the “primary outcome.”
Objective Response Rate
Measured over: Up to 60 months
Changes Tremor has spotted
No changes since Tremor started watching this trial.
Show details (technical version)
Score inputs
- none
Raw record changes
- none yet
Trial ID NCT04614103 · record last updated 2026-06-26 · checked 2026-11-09 15:47 UTC